MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status

International Journal of Cancer - United States
doi 10.1002/ijc.26256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Correction: Cisplatin-Induced Epigenetic Activation of miR-34a Sensitizes Bladder Cancer Cells to Chemotherapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2017English

miR‑34a Regulates the Chemosensitivity of Retinoblastoma Cells via Modulation of MAGE‑A/p53 Signaling

International Journal of Oncology
Cancer ResearchOncology
2018English

MicroRNA-34a (miR-34a)

Science-Business eXchange
2011English

MicroRNA-34a Is Induced via P53 During Cisplatin Nephrotoxicity and Contributes to Cell Survival

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2010English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

2012English

Tumor-Suppressive miR-34a Induces Senescence-Like Growth Arrest Through Modulation of the E2F Pathway in Human Colon Cancer Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Elevated Circulating Stearic Acid Leads to a Major Lipotoxic Effect on Mouse Pancreatic Beta Cells in Hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent Pathway

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy